NCT00649740View on ClinicalTrials.gov

Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Healthy
Interventions
DRUG

Topiramate Sprinkle Capsules 25 mg

25mg, single dose fasting

DRUG

Topamax® Sprinkle Capsule 25 mg

25mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649740 - Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg | Biotech Hunter | Biotech Hunter